-

Maggie Anderson Joins JLL Partners as an Operating Partner

NEW YORK--(BUSINESS WIRE)--JLL Partners, LLC (“JLL” or the “Firm”), a New York-based middle market private equity firm focused on investing in businesses in the healthcare, aerospace and defense, and business services sectors, today announced that Maggie Anderson has joined the Firm as an Operating Partner.

Ms. Anderson possesses more than 25 years of collective experience in healthcare, private equity, and management consulting. Prior to joining JLL Ms. Anderson was an SVP at DaVita, a global Fortune 500 healthcare delivery company. While there, she was responsible for managing approximately $1 billion P&L, leading 275 dialysis centers and 140 home dialysis programs across 13 states, and served as President of Lifeline Vascular Care, a healthcare management company that partners with physicians to acquire or develop ambulatory surgery centers. Ms. Anderson led the spin-out of Lifeline from DaVita. Prior to joining DaVita, she was the President of Biomet 3i, a global dental implant company. Before that, she was an Operating Partner at TPG, Director at AlixPartners and held a variety of leadership positions at GM Powertrain, including operations, engineering, and product development.

“Throughout her expansive career, Maggie has built trusted partnerships with management, successfully navigating complex challenges to drive tangible growth,” said the Managing Partners of JLL. “Her depth of experience will strengthen JLL’s capabilities as we scale and position our portfolio companies for long-term success.”

Ms. Anderson earned an MBA from Wright State University and a Bachelor of Science degree from the General Motors Engineering & Management Institute.

About JLL Partners

JLL Partners, LLC is a middle market private equity firm with over three decades of experience transforming businesses in the healthcare, aerospace and defense, and business services sectors. JLL is dedicated to partnering with companies that it believes it can help build into market leaders through a combination of strategic mergers and acquisitions, organic growth initiatives, and operational enhancements. The JLL team is comprised of seasoned investment professionals and operating partners who are focused on driving long-term value creation across its portfolio. Since its founding in 1988, JLL has invested and committed approximately $8 billion of equity capital across nine private equity funds, with 60 platform investments and 184 add-on acquisitions.

For additional information, please visit www.jllpartners.com.

Contacts

Eli Kapsack
Profile Advisors
ekapsack@profileadvisors.com

JLL Partners


Release Versions

Contacts

Eli Kapsack
Profile Advisors
ekapsack@profileadvisors.com

More News From JLL Partners

JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics

NEW YORK--(BUSINESS WIRE)--JLL Partners (“JLL” or the “Firm”), a New York-based middle market private equity firm focused on investing in the healthcare, aerospace and defense, and business services sectors, today announced its acquisition of Parks Medical Electronics (“Parks” or the “Company”), a leading manufacturer of medical Doppler ultrasound systems for use in hospital, clinic, and veterinary settings, and the Flo-Lab Vascular system, a diagnostic tool used to evaluate blood flow in patie...

JLL Partners Announces Hiring of Jeff Hunter as Chief AI Officer

NEW YORK--(BUSINESS WIRE)--JLL Partners, LLC (“JLL” or “the Firm”), a New York-based middle market private equity firm focused on investing in businesses in the healthcare, aerospace and defense, and business services sectors, today announced that Jeff Hunter has joined the Firm as Chief AI Officer. Mr. Hunter will oversee the AI function at JLL and lead the Firm’s efforts to effectively utilize and leverage artificial intelligence and new technology solutions to help drive continued growth. Mr...

JLL Partners Announces Investment in Vascular Technology, Incorporated

NEW YORK--(BUSINESS WIRE)--JLL Partners (“JLL” or the “Firm”), a New York-based middle market private equity firm focused on investing in the healthcare, aerospace and defense, and business services sectors, today announced its investment in Vascular Technology, Incorporated (“VTI” or the “Company”), a medical device company specializing in innovative surgical devices and single-use consumables for the operating room. Through this transaction, JLL partnered with entrepreneur Nilendu Srivastava...
Back to Newsroom